Article
01 Sep 2023
Attorney Says PCCPs With Change In Indication For Use Not Completely Impracticable
AUTHORS CONTENT
Article
03 Aug 2023
5 Questions About Generative AI In Healthcare
Article
28 Jul 2023
FDA's Decentralized Trial Guidance: Investigator, Health Care Provider Demarcation Raises Questions
Article
05 Jul 2023
The EU's New Proposal For Plants Developed Using New Genomic Techniques: How Does It Compare To U.S. Regulation?
Article
19 Jun 2023
Will FDA's Accelerated Approval Pathway Facilitate Access To Gene Therapies As Applications Roll In?
Article
23 May 2023
FDA On Use Of AI/ML In Drug Development: Five Key Takeaways
Article
17 May 2023
FTC Issues Notice Of Penalty Offenses On Substantiation Of Product Claims
Article
10 May 2023
FDA Publishes Draft Guidance For Predetermined Change Control Plan For AI/ML-Enabled Device Software Functions
Article
12 Apr 2023
FDA Issues Final Transition Guidances For COVID-19 Devices
Article
05 Apr 2023
FDA Releases Draft Guidance For Labeling Of Plant-Based Milk Alternatives
